Literature DB >> 33956050

Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce.

Li Tang1, Diego R Hijano2, Aditya H Gaur2, Terrence L Geiger3, Ellis J Neufeld4, James M Hoffman5, Randall T Hayden3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33956050      PMCID： PMC8220512          DOI： 10.1001/jama.2021.6564

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  Recommendations for the use of Taylor series confidence intervals for estimates of vaccine efficacy.

Authors:  A W Hightower; W A Orenstein; S M Martin
Journal:  Bull World Health Organ       Date:  1988       Impact factor: 9.408

2.  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

Authors:  Fernando P Polack; Stephen J Thomas; Nicholas Kitchin; Judith Absalon; Alejandra Gurtman; Stephen Lockhart; John L Perez; Gonzalo Pérez Marc; Edson D Moreira; Cristiano Zerbini; Ruth Bailey; Kena A Swanson; Satrajit Roychoudhury; Kenneth Koury; Ping Li; Warren V Kalina; David Cooper; Robert W Frenck; Laura L Hammitt; Özlem Türeci; Haylene Nell; Axel Schaefer; Serhat Ünal; Dina B Tresnan; Susan Mather; Philip R Dormitzer; Uğur Şahin; Kathrin U Jansen; William C Gruber
Journal:  N Engl J Med       Date:  2020-12-10       Impact factor: 91.245

3.  BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.

Authors:  Noa Dagan; Noam Barda; Eldad Kepten; Oren Miron; Shay Perchik; Mark A Katz; Miguel A Hernán; Marc Lipsitch; Ben Reis; Ran D Balicer
Journal:  N Engl J Med       Date:  2021-02-24       Impact factor: 91.245

4.  Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.

Authors:  Sharon Amit; Gili Regev-Yochay; Arnon Afek; Yitshak Kreiss; Eyal Leshem
Journal:  Lancet       Date:  2021-02-18       Impact factor: 79.321
  4 in total
  31 in total

1.  Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States.

Authors:  Sally B Coburn; Elizabeth Humes; Raynell Lang; Cameron Stewart; Brenna C Hogan; Kelly A Gebo; Sonia Napravnik; Jessie K Edwards; Lindsay E Browne; Lesley S Park; Amy C Justice; Kirsha S Gordon; Michael A Horberg; Julia M Certa; Eric Watson; Celeena R Jefferson; Michael J Silverberg; Jacek Skarbinski; Wendy A Leyden; Carolyn F Williams; Keri N Althoff
Journal:  JAMA Netw Open       Date:  2022-06-01

2.  A Macro-Level Association of Vaccination Rate with the Number of Confirmed COVID-19 Cases in the United States and Japan.

Authors:  Hiroyuki Noda
Journal:  Int J Environ Res Public Health       Date:  2022-06-17       Impact factor: 4.614

3.  Individual-based modeling reveals that the COVID-19 isolation period can be shortened by community vaccination.

Authors:  Chayanin Sararat; Jidchanok Wangkanai; Chaiwat Wilasang; Tanakorn Chantanasaro; Charin Modchang
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

Review 4.  [COVID-19 with respect to occupational healthcare and public health services].

Authors:  Sabine Wicker; Pia Behrens; René Gottschalk
Journal:  Internist (Berl)       Date:  2021-08-18       Impact factor: 0.743

5.  Clinical Phenotype and Contagiousness of Early Breakthrough SARS-CoV-2 Infections after BNT162b2 COVID-19 mRNA Vaccine: A Parallel Cohort Study in Healthcare Workers.

Authors:  Mattia Trunfio; Federica Verga; Valeria Ghisetti; Elisa Burdino; Teresa Emanuele; Stefano Bonora; Giovanni Di Perri; Andrea Calcagno
Journal:  Vaccines (Basel)       Date:  2021-11-23

6.  A systematic review of methodological approaches for evaluating real-world effectiveness of COVID-19 vaccines: Advising resource-constrained settings.

Authors:  Yot Teerawattananon; Thunyarat Anothaisintawee; Chatkamol Pheerapanyawaranun; Siobhan Botwright; Katika Akksilp; Natchalaikorn Sirichumroonwit; Nuttakarn Budtarad; Wanrudee Isaranuwatchai
Journal:  PLoS One       Date:  2022-01-11       Impact factor: 3.240

7.  SARS-CoV-2 Infections in mRNA Vaccinated Individuals are Biased for Viruses Encoding Spike E484K and Associated with Reduced Infectious Virus Loads that Correlate with Respiratory Antiviral IgG levels.

Authors:  Heba H Mostafa; Chun Huai Luo; C Paul Morris; Maggie Li; Nicholas J Swanson; Adannaya Amadi; Nicholas Gallagher; Andrew Pekosz
Journal:  medRxiv       Date:  2021-07-07

8.  Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021.

Authors:  Thomas Harder; Judith Koch; Sabine Vygen-Bonnet; Wiebe Külper-Schiek; Antonia Pilic; Sarah Reda; Stefan Scholz; Ole Wichmann
Journal:  Euro Surveill       Date:  2021-07

9.  The association between adverse reactions and immune response against SARS-CoV-2 spike protein after vaccination with BNT162b2 among healthcare workers in a single healthcare system: a prospective observational cohort study.

Authors:  Daisuke Jubishi; Koh Okamoto; Kensuke Hamada; Takashi Ishii; Hideki Hashimoto; Takayuki Shinohara; Marie Yamashita; Yuji Wakimoto; Amato Otani; Naoko Hisasue; Mahoko Ikeda; Sohei Harada; Shu Okugawa; Kyoji Moriya; Shintaro Yanagimoto
Journal:  Hum Vaccin Immunother       Date:  2022-03-25       Impact factor: 4.526

Review 10.  Accelerated COVID-19 vaccine development: milestones, lessons, and prospects.

Authors:  Karin Bok; Sandra Sitar; Barney S Graham; John R Mascola
Journal:  Immunity       Date:  2021-08-03       Impact factor: 31.745
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.